Merck & Co
As on 03 Oct, 2025 | 23:17 IST
| Open | 89.56 |
| Previous Close | 89.51 |
| Beta | 0.35 |
| High | 90.70 |
| Low | 88.14 |
| TTM EPS See historical trend | 7.64(+17.36% YoY) |
| 52 Week High | 111.57 |
| 52 Week Low | 73.35 |
| TTM PE See historical trend | 11.80(Low PE) |
| Mkt. Cap ($ Billion) | 228.39 |
| Dividend Yield | 4.04 |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 86.47 |
| 10 | 82.85 |
| 20 | 82.78 |
| 50 | 82.9 |
| 100 | 81.25 |
| 200 | 86.09 |
Returns
| 1 Week | 12.78% | |
| 1 Month | 7.19% | |
| 3 Months | 13.86% | |
| YTD | -9.22% | |
| 1 Year | -20.59% | |
| 3 Years | 4.71% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | 732.30 | -0.25 | 695.17 | 123.70 | 5.92 | 0.96 | 746.56/0.00 | -13.33 | Neutral |
| J&J | 177.18 | -0.49 | 426.52 | 16.89 | 10.49 | 2.88 | 178.99/0.00 | 13.43 | Neutral |
| AbbVie | 207.90 | -0.08 | 366.95 | 17.44 | 11.92 | 4.39 | 210.41/0.00 | 7.73 | Bearish |
| Abbott | 131.38 | -0.06 | 227.99 | 30.70 | 4.28 | 1.87 | 131.66/0.00 | 0.58 | Bearish |
| Merck | 81.45 | -1.64 | 206.68 | 26.36 | 3.09 | 2.53 | 85.18/0.00 | -1.89 | Bearish |
Market news
- Wall Street ends streak of weekly gains, yields rise as investors digest dataSeptember 27, 2025 8:50 AM
- Stocks finish week higher; Wall Street at record highsSeptember 20, 2025 7:43 AM
- Nasdaq notches record high close, traders look to Fed meetingSeptember 13, 2025 9:16 AM
- Wall Street indexes end lower as jobs data fuels economic worriesSeptember 6, 2025 10:13 AM
About the company
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.